Study to Assess Tolerability, Safety and Pharmacokinetics of a New Drug

Inclusion Criteria: * Male patient, aged between 18 and 50 years; * Body weight ≥ 50 kg and BMI ≥ 18.5 kg/m2 and ≤ 30 kg/m2; * Healthy men accordance with their historical and tests; * Healthy subject with laboratory results within the normal range or within the parameters accepted by the clinical protocol * Negative results for parasitological stool examination performed in the clinical study; * Subject of research with laboratory results within the normal range for urinalysis collected before the first visit; * Research subjects allocated in Group 6 with endoscopy within the normal range; Exclusion Criteria: * History of gastrointestinal disease, hepatic, renal, cardiovascular, pulmonary, neurologic, hematologic, diabetes or glaucoma; * Evidence on clinical examination or physical or complement, organ dysfunction or any clinically significant deviation from normality; * History of use of psychotropic drugs or excessive alcohol consumption (more than two units of alcohol per day, one unit being equivalent to one cup (200 mL) of brew or a dose (50) mL of distilled beverage) or having difficulty to abstain during the study; * Use of any medication two (2) weeks prior to inclusion of the research subject in the study; * Regular smokers or who quit less than one (1) year; * History of food allergy or hyperreactivity to medications or foods; * HIV positive for HIV; * Being positive for Hepatitis B; * Being positive for hepatitis C; * Testing positive for Helicobacter pilorum; * Using substances modulating hepatic microsomal activity within thirty (30) days prior to entry of the subject of research in the clinical study (date of signing the consent form); * Having donated blood (blood volume higher than 500 mL) within four (4) months preceding the date of signing the consent form; * Subject with a history of hypersensitivity to any component of the investigational product;